Please check your internet connection and try again.
# Sodium Phosphate Enema
## Overview
Sodium phosphate enema is a hypertonic saline laxative that works by drawing water into the colon, stimulating bowel evacuation.
## Primary Indications
* Bowel preparation prior to colonoscopy or surgery.
* Relief of occasional constipation.
## Adult Dosing
* **Bowel Preparation:** Typically, one 4.5 oz (133 mL) enema administered 3-5 hours prior to the procedure. Some protocols may recommend a second dose. Follow specific institutional guidelines.
* **Constipation:** One 4.5 oz (133 mL) enema may be administered. Not intended for chronic use.
## Pediatric Dosing
* **Ages 2-5 years:** Half the adult dose (approximately 2.25 oz or 67 mL). Use with caution and close monitoring.
* **Ages 6-12 years:** One 2.25 oz (67 mL) enema.
* **Under 2 years:** Generally not recommended due to increased risk of electrolyte disturbances. Consult with a pediatrician or specialist.
## Dose Adjustments
* No specific dose adjustments are typically required for renal or hepatic impairment, however, caution is advised due to the risk of electrolyte imbalances, especially in patients with pre-existing renal disease.
## Contraindications
* Congestive heart failure.
* Acute renal insufficiency.
* Congenital megacolon.
* Intestinal obstruction or perforation.
* Children under 2 years of age.
* Patients with ileostomy or colostomy.
* Patients with nausea, vomiting, abdominal pain, or other symptoms of appendicitis or undiagnosed abdominal pain.
## Adverse Effects
* **Common:** Abdominal cramping, bloating, nausea, vomiting, rectal irritation.
* **Serious:**
* **Electrolyte Imbalances:** Hyperphosphatemia, hypocalcemia, hypernatremia, hyponatremia, metabolic acidosis. This is a significant risk, particularly in children, the elderly, and those with renal impairment.
* **Dehydration.**
* **Renal damage:** Acute kidney injury.
* **Rectal ulceration and perforation** (rare).
## Key Drug Interactions
* **Diuretics:** Increased risk of dehydration and electrolyte disturbances.
* **ACE inhibitors and ARBs:** Increased risk of hyperkalemia.
* **Diuretics, ACE inhibitors, ARBs, NSAIDs, and diuretics:** Increased risk of renal impairment when used concurrently with sodium phosphate.
## Monitoring
* Monitor for signs and symptoms of dehydration and electrolyte imbalances (e.g., dizziness, fatigue, muscle cramps, confusion, decreased urine output).
* Electrolyte levels (phosphate, calcium, sodium, potassium) may be considered, especially in at-risk populations or if symptoms arise.
* Renal function (BUN, creatinine).
## Clinical Pearls
* Due to the risk of serious electrolyte disturbances and renal injury, sodium phosphate enemas should be used judiciously.
* Ensure adequate hydration before and after administration, especially for bowel preparation.
* Patient education on proper administration technique is crucial.
* Advise patients to contact a healthcare provider if they experience severe cramping, bleeding, or no bowel movement after administration.
***
*Disclaimer: This information is intended for healthcare professionals. Always consult the official prescribing information and institutional protocols for complete and up-to-date guidance.*
